Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis (ATaC-MS): A Phase 2a Clinical Trial

Authors
Category Primary study
ConferenceACTRIMS Forum 2025
Year 2025
This article has no abstract
Epistemonikos ID: 54e21631c1d56a9dea28d7fb61f81af7fa633ec4
First added on: Jan 31, 2026